Biosimilars: a cheaper and effective alternative to branded drugs
The European Commission’s pharmaceutical reform would improve access to cheaper biosimilar medicines and speed up market access. Connie Ziegler was diagnosed with rheumatoid arthritis when she was a young girl. “When I was about a year and a half old, my parents told me that my knees were starting to hurt especially. And that I …